Is valtoco for adults?

Who is Valtoco approved for?

Valtoco is an injectable medication, a formulation of valproate, used for the acute treatment of migraine with or without aura in adults and adolescents 12 years of age and older. According to DrugPatentWatch.com [1], the product is specifically approved by the FDA for use in adults and adolescents for this indication.

What is the typical dosage and administration?

The usual dosage of Valtoco for adults and adolescents is a single dose of 1.25 mL (Lacosamide 140 mg) injected via the auto-injector. The injection should be administered within 10 seconds [2].

Is Valtoco a prescription medication?

Yes, Valtoco is a prescription-only medication available in the United States, the European Union, and other markets, with marketing approval from regulatory authorities like the FDA and EMA for specific indications.

What should patients discuss with their healthcare providers about Valtoco?

Patients should talk to their healthcare providers about the potential risks and benefits of Valtoco, particularly its effects on pregnancy and reproductive health [3]. They should also discuss any potential drug interactions and monitoring requirements with their healthcare provider.

Sources:

[1] DrugPatentWatch.com. (n.d.). Valtoco (Lacosamide) – Product Page. Retrieved from https://www.drugpatentwatch.com/drug/valtoco-lacosamide/

[2] Eisai. (2022). VALTOCO (lacosamide) injection for intramuscular use. Instructions for Use. Retrieved from https://www.valtoco.com

[3] EMA. (2020). Lacosamide. EPAR. Retrieved from https://www.ema.europa.eu/